11-1835887-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001394072.1(SYT8):āc.260T>Gā(p.Val87Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,611,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001394072.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYT8 | NM_001394072.1 | c.260T>G | p.Val87Gly | missense_variant, splice_region_variant | 3/8 | ENST00000341958.4 | NP_001381001.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYT8 | ENST00000341958.4 | c.260T>G | p.Val87Gly | missense_variant, splice_region_variant | 3/8 | 5 | NM_001394072.1 | ENSP00000343691.3 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152204Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000121 AC: 30AN: 248790Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 135014
GnomAD4 exome AF: 0.000258 AC: 377AN: 1459640Hom.: 0 Cov.: 41 AF XY: 0.000240 AC XY: 174AN XY: 726198
GnomAD4 genome AF: 0.000158 AC: 24AN: 152204Hom.: 0 Cov.: 35 AF XY: 0.000175 AC XY: 13AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.302T>G (p.V101G) alteration is located in exon 4 (coding exon 4) of the SYT8 gene. This alteration results from a T to G substitution at nucleotide position 302, causing the valine (V) at amino acid position 101 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at